<unk>  affects approximately 1 per 1,000 people (0.1%), while there are 25–30 new cases per 100,000 people per year in the United States. The prevalence of<unk>  has been estimated to be 3 in 1000 in the general population and as high as 21 in 1000 in postmenopausal women. It is almost exactly three times as common in women as men.<unk>  is associated with increased all-cause mortality.
Primary hyperparathyroidism
Secondary hyperparathyroidism
Tertiary hyperparathyroidism
Familial hypocalciuric hypercalcemia
Parathyroid adenoma
Pseudohypoparathyroidism
Normophosphatemic familial tumoral calcinosis
Pseudopseudohypoparathyroidism